It seems the content is not visible or provided. Please share the content you'd like summarized, and I'd be happy to help!
NVS has been in the news recently: Novartis AG will acquire Avidity Biosciences for $12 billion, paying $72 per share, with the deal expected to close in the first half of 2026. Following the announcement, Avidity Biosciences' shares experienced a surge in premarket trading.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.